SCCs more deadly in the immunosuppressed
Not only are immunosuppressed people at increased risk of developing skin cancer, new research shows the skin cancer they get is more likely to be aggressive and multifocal.
According to the retrospective study of a cohort of almost 800 patients who had been treated for cutaneous SCC of the head and neck at a US tertiary cancer care centre, immunosuppression was found to be independently associated with a worse outcome.
In fact, when compared to similar SCC patients who were not immunosuppressed, those whose immune system was compromised were almost two and a half times more likely to die from the cancer, even after adjusting for such factors as age and history of skin cancer.
The study found five-year disease-specific survival was 68.2% in the group with immunosuppression compared with ...